Impexpharm (შპს იმპექსფარმი)

panel 2026-09-21Ask

as filed · GEL, thousands

Line item	2017	2018	2019	2020	2021	2022	2023	2024	CAGR
	24,266	38,238	47,042	51,688	55,427	54,681	53,727	50,341	+11.0%
	10,839	3,820	17,433	21,022	28,519	31,983	37,267	43,216	+21.8%
TOTAL ASSETS	35,105	42,058	64,475	72,709	83,945	86,664	90,995	93,557	+15.0%
	3,304	5,019	7,365	7,482	8,667	7,818	11,595	14,987	+24.1%
	0	0	13,841	15,139	16,722	15,663	19,252	18,266	+5.7%
TOTAL LIABILITIES	3,304	5,019	21,206	22,620	25,388	23,481	30,847	33,253	+39.1%
	31,801	37,039	43,269	50,089	58,557	63,184	60,147	60,304	+9.6%
Balance Check (Assets - L&E)	0	0	0	0	0	0	0	0
Debt analysis
Total Debt	0	0	13,841	15,139	16,722	15,663	19,252	18,266	+5.7%
Cash & Equivalents	3,861	11,792	4,308	9,828	14,283	12,941	7,652	3,447	-1.6%
Net Debt	3,861	11,792	9,533	5,310	2,438	2,722	11,600	14,819	nmf

Impexpharm